New Products: Imaging system that helps detect cervical Ca approved by FDA

BD says reducing false-negative findings and interpretation errors is the system's goal. That's accomplished through "state-of-the-art" guided screening technology for rapidly relocating the fields of view that the system identifies as likeliest to contain cells of interest.

For more information, visit the company's Web site at http://www.bd.com/.